Several FDA-approved drugs—including for type 2 diabetes, hepatitis C and HIV—significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists ...
Feb 25, 2022
2
292
Scientists at Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH) have identified a promising drug candidate for the treatment of multi-inflammatory syndrome in children (MIS-C), they report in Clinical ...
Feb 24, 2022
0
4
Scientists at the Max Planck Institute for Medical Research in Heidelberg and their collaborators at the Max Planck Bristol Center for Minimal Biology at the University of Bristol have developed a new approach to study SARS-CoV-2. ...
Feb 21, 2022
0
436
T-cell responses directed against the receptor-binding domain of the SARS-CoV-2 spike protein were associated with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer, with lower T-cell responses ...
Feb 18, 2022
0
23
(HealthDay)—For patients undergoing hemodialysis, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA-1273 vaccine elicits a stronger humoral response than the BNT162b2 vaccine, according to a study published ...
Feb 16, 2022
0
4
A future vaccine providing protection against a wide range of coronaviruses that jump from their original animal hosts to humans—including SARS-CoV-2, the cause of COVID-19—may be possible, say Johns Hopkins Medicine ...
Feb 16, 2022
0
5
Australian Health Minister Greg Hunt said last week he expects the Australian Technical Advisory Group on Immunisation (ATAGI) to change the definition of "fully vaccinated" to three doses instead of two.
Feb 8, 2022
0
2
A new study has shown how SARS-CoV-2 may contribute to severe microvascular damage seen in severely-ill COVID-19 patients by transforming human heart vascular cells into inflammatory cells, without infecting them. The University ...
Feb 3, 2022
2
205
Mutations to the spike protein of the omicron variant are shown to alter how the virus infects cells and reduce its sensitivity to therapeutic and vaccine-elicited antibodies, according to a paper published in Nature. Booster ...
Feb 3, 2022
0
35
A team co-led by scientists at Scripps Research has found evidence that a compound contained in the medicinal and culinary herb rosemary could be a two-pronged weapon against the SARS-CoV-2 coronavirus that causes COVID-19.
Feb 1, 2022
0
1099
